HIKMA FARMACEUTICA (PORTUGAL) SA. secures contract for Call For Proposals Under Framework Agreement(S) 304/2023 - Group 4 Medicines: Blood, 490/2023 - Medicines Used In Skin Conditions, 495/2023 - Device Medicines

Portugal, July 8 -- Portugal based HIKMA FARMACEUTICA (PORTUGAL) SA. has secured contract from Unidade Local De Saude De Lisboa Ocidental, E. P. E. for Call For Proposals Under Framework Agreement(S) 304/2023 - Group 4 Medicines: Blood, 490/2023 - Medicines Used In Skin Conditions, 495/2023 - Device Medicines . The value of the contract is worth 11324.28 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....